Deutsche Bank
NVCT icon

Deutsche Bank’s Nuvectis Pharma NVCT Stock Holding History

Deutsche Bank’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Buy
16,874
+4,202
+33% +$47K ﹤0.01% 3022
2026
Q1 		$98K Hold
12,672
– – ﹤0.01% 3288
2025
Q4 		$95.7K Buy
12,672
+12,336
+3,671% +$80.4K ﹤0.01% 3307
2025
Q3 		$2.02K Sell
336
-12,614
-97% -$86.7K ﹤0.01% 3564
2025
Q2 		$96.7K Buy
+12,950
New +$117K ﹤0.01% 3272
2024
Q2 		– Sell
-3,509
Closed -$28.8K – 3654
2024
Q1 		$28.8K Buy
+3,509
New +$29.8K ﹤0.01% 3474

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Deutsche Bank's NVCT Position: Q2 2026 in Review

Deutsche Bank increased its Nuvectis Pharma (NVCT) stake by 33% in Q2 2026, buying an estimated $47K and bringing the position to 16,874 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #3022.

Deutsche Bank first reported a position in NVCT in Q1 2024 and has held it in 6 quarters since. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Deutsche Bank held 16,874 shares of Nuvectis Pharma worth $310K as of Q2 2026.
  • Deutsche Bank bought 4,202 Nuvectis Pharma shares in Q2 2026, an estimated $47K.
  • Nuvectis Pharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3022 holding.
  • Deutsche Bank first reported a position in Nuvectis Pharma in Q1 2024 and has held it in 6 quarters since.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.